Eukaryotic-microbiota crosstalk: Potential mechanisms for health benefits of prebiotics and probiotics

Annual Review of Nutrition

Volumn 28, Issue , 2008, Pages 215-231

  Hord, Norman G ^a  

^a Michigan State University   (United States)

Author keywords

Microbiome; Mucosal immunity; Mutualism; Prebiotic; Probiotic

Indexed keywords

BETA INTERFERON; CANNABINOID RECEPTOR; CD209 ANTIGEN; FLAGELLIN; INTERLEUKIN 10; LACTOBACILLUS ACIDOPHILUS NCFM; LACTOBACILLUS JOHNSONII LA 1; LACTOBACILLUS PARACASEI NCC2461; LIPOPOLYSACCHARIDE; MU OPIATE RECEPTOR; NATURAL PRODUCT; PEPTIDOGLYCAN; PREBIOTIC AGENT; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTEROIDES FRAGILIS; BIFIDOBACTERIACEAE; BIOTA; BLOOD PRESSURE REGULATION; CELL INTERACTION; ENERGY BALANCE; ENTERITIS; EUKARYOTE; EUKARYOTIC PROBIOTIC INTERACTION; EVIDENCE BASED MEDICINE; FOOD COMPOSITION; FOOD INTAKE; FOOD MICROBIOTECHNOLOGY; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; IMMUNE FUNCTION TEST; INTESTINE FUNCTION; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MICROBIOTA; MUCOSA ASSOCIATED LYMPHOID TISSUE; NASAL ASSOCIATED LYMPHOID TISSUE; NEUROEPITHELIUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY EPITHELIUM; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; SUPRACHIASMATIC NUCLEUS; SYMBIOSIS; SYMPATHETIC NERVE; UROGENITAL SYSTEM;

HEALTH STATUS; HUMANS; IMMUNE SYSTEM; INTESTINES; OLIGOSACCHARIDES; PROBIOTICS;

ARCHAEA; BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 50949116215     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.28.061807.155402     Document Type: Review

References (83)

1. Abreu MT, Fukata M, Arditi M. 2005. TLR signaling in the gut in health and disease. J. Immunol. 174:4453-60
2. Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, et al. 2005. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 94:452-81
3. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-20
4. Bengmark S. 1999. Gut microenvironment and immune function. Curr. Opin. Clin. Nutr Metab. Care 2:83-85
5. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, et al. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651-59
6. Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, et al. 1989. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 97:1562-84
7. Cario E, Gerken G, Podolsky DK. 2004. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127:224-38
8. Cario E, Podolsky DK. 2005. Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol. Immunol. 42:887-93
9. Chae S, Eckmann L, Miyamoto Y, Pothoulakis C, Karin M, Kagnoff MF. 2006. Epithelial cell I kappa B-kinase β has an important protective role in Clostridium difficile toxin A-induced mucosal injury. J. Immunol. 177:1214-20
10. Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D. 2006. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study. Minerva Gastroenterol. Dietol. 52:349-58
11. Dickersin K, Straus SE, Bero LA. 2007. Evidence based medicine: increasing, not dictating, choice. BMJ 334(Suppl. 1):S10
12. Doron S, Snydman DR, Gorbach SL. 2005. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol. Clin. North Am. 34:483-98, ix
13. Douglas LC, Sanders ME. 2008. Probiotics and prebiotics in dietetics practice. J. Am. Diet. Assoc. 108:510-21
14. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-38
15. Fink LN, Zeuthen LH, Ferlazzo G, Frokiaer H. 2007. Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation. FEMS Immunol. Med. Microbiol. 51:535-46
16. Food and Agricultural Org., World Health Org. 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. http://www.who.int/foodsafety/publications/ fs_management/probiotics/en/index.html
17. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, et al. 2006. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131:862-77
18. Furness J. 2005. The Enteric Nervous System. Oxford, UK: Blackwell Publ.
19. Galdeano CM, de Moreno de LeBlanc A, Vinderola G, Bonet ME, Perdigon G. 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 14:485-92
20. Galdeano CM, Perdigon G. 2006. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13:219-26
21. Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. 2007. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56:1522-28
22. Gareau MG, Jury J, Perdue MH. 2007. Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G198-203
23. Gershon MD. 1999. The enteric nervous system: a second brain. Hosp. Pract. (Minneap.) 34:31-32, 35-38, 41-42
24. Gershon MD, Tack J. 2007. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397-414
25. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-59
26. Gluck U, Gebbers JO. 2003. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and β-hemolytic streptococci). Am. J. Clin. Nutr. 77:517-20
27. Gordon JI, Hooper LV, McNevin MS, Wong M, Bry L. 1997. Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. Am. J. Physiol. 273:G565-70
28. Grundy D. 2006. Signalling the state of the digestive tract. Auton. Neurosci. 125:76-80
29. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, et al. 2004. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines." J. Am. Acad. Dermatol. 50:391-404
30. He B, Xu W, Santini PA, Polydorides AD, Chiu A, et al. 2007. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26:812-26
31. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. 1998. Overview of gut flora and probiotics. Int. J. Food Microbiol. 41:85-101
32. Isolauri E, Rautava S, Kalliomaki M, Kirjavainen P, Salminen S. 2002. Probiotic research: learn from the evidence. Allergy 57:1076-77; author reply 1078
33. Kalliomaki M, Collado MC, Salminen S, Isolauri E. 2008. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 87:534-38
34. Kim JG, Lee SJ, Kagnoff MF. 2004. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors. Infect. Immun. 72:1487-95
35. Kim YG, Park JH, Shaw MH, Franchi L, Inohara N, Nunez G. 2008. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28:246-57
36. Kirjavainen PV, Salminen SJ, Isolauri E. 2003. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 36:223-27
37. Kopp MV, Goldstein M, Dietschek A, Sofke J, Heinzmann A, Urbanek R. 2008. Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates. Clin. Exp. Allergy 38(4):602-10
38. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, et al. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617-23
39. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, et al. 2006. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8:1327-36
40. Lee J, Rachmilewitz D, Raz E. 2006. Homeostatic effects of TLR9 signaling in experimental colitis. Ann. N.Y. Acad. Sci. 1072:351-55
41. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, et al. 2007. Probiotic and prebiotic influence beyond the intestinal tract. Nutr. Rev. 65:469-89
42. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102:11070-75
43. Ley RE, Knight R, Gordon JI. 2007. The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. Environ. Microbiol. 9:3-4
44. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-48
45. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-23
46. Liu CH, Lee SM, Vanlare JM, Kasper DL, Mazmanian SK. 2008. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc. Natl. Acad. Sci. USA 105:3951-56
47. Liu M, Geddis MS, Wen Y, Setlik W, Gershon MD. 2005. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G1148-53
48. Lu Q, Samaranayake LP, Darveau RP, Jin L. 2005. Expression of human beta-defensin-3 in gingival epithelia. J. Periodontal. Res. 40:474-81
49. Macfarlane S, Macfarlane GT, Cummings JH. 2006. Review article: prebiotics in the gastrointestinal tract. Aliment. Pharmacol. Ther. 24:701-14
50. Mach T. 2004. The brain-gut axis in irritable bowel syndrome - clinical aspects. Med. Sci. Monit. 10:RA125-31
51. Marteau P, Lemann M, Seksik P, Laharie D, Colombel JF, et al. 2006. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55:842-47
52. Metchnikoff E. 1907. The Prolongation of Life. New York: Putnam & Sons
53. Metchnikoff E. 1908. Etudes sur la flore intestinale. Ann. Inst. Pasteur Paris 22:929-55
54. Noverr MC, Huffnagle GB. 2004. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 12:562-68
55. O'Hara AM, Shanahan F. 2007. Mechanisms of action of probiotics in intestinal diseases. Sci. World J. 7:31-46
56. O'Mahony L, O'Callaghan L, McCarthy J, Shilling D, Scully P, et al. 2006. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G839-45
57. O'Sullivan MA, O'Morain CA. 2000. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig. Liver Dis. 32:294-301
58. Ozinsky A, Smith KD, Hume D, Underhill DM. 2000. Co-operative induction of proinflammatory signaling by Toll-like receptors. J. Endotoxin. Res. 6:393-96
59. Penner R, Fedorak RN, Madsen KL. 2005. Probiotics and nutraceuticals: nonmedicinal treatments of gastrointestinal diseases. Curr. Opin. Pharmacol. 5:596-603
60. Perdigon G, Medina M, Vintini E, Valdez JC. 2000. Intestinal pathway of internalisation of lactic acid bacteria and gut mucosal immunostimulation. Int. J. Immunopathol. Pharmacol. 13:141-50
61. Peterson DA, McNulty NP, Guruge JL, Gordon JI. 2007. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host. Microbe 2:328-39
62. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, et al. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126:520-28
63. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229-41
64. Rastall RA, Gibson GR, Gill HS, Guarner F, Klaenhammer TR, et al. 2005. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol. Ecol. 52:145-52
65. Reid G, Beuerman D, Heinemann C, Bruce AW. 2001. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32:37-41
66. Rescigno M. 2003. Identification of a new mechanism for bacterial uptake at mucosal surfaces, which is mediated by dendritic cells. Pathol. Biol. (Paris) 51:69-70
67. Rescigno M. 2006. CCR6(+) dendritic cells: the gut tactical-response unit. Immunity 24:508-10
68. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, et al. 2005. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6:507-14
69. Roberfroid M. 2007. Prebiotics: the concept revisited. J. Nutr. 137:830-37S
70. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, et al. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 13:35-37
71. Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, et al. 2006. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24:623-32
72. Sanders ME GG, Guarner HS, Gill F. 2007. Probiotics: their potential to impact human health. Issue pap., Counc. Agric. Sci. Technol., Ames, IA
73. Sartor RB. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620-33
74. Savage DC. 1986. Gastrointestinal microflora in mammalian nutrition. Annu. Rev. Nutr. 6:155-78
75. Smits HH, Engering A, Van Der Kleij D, de Jong EC, Schipper K, et al. 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115:1260-67
76. Tanida M, Yamano T, Maeda K, Okumura N, Fukushima Y, Nagai K. 2005. Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Neurosci. Lett. 389:109-14
77. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. 2001. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin. Proc. 76:883-89
78. Tomczak MF, Erdman SE, Davidson A, Wang YY, Nambiar PR, et al. 2006. Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B. J. Immunol. 177:7332-39
79. Tuomilehto J, Lindstrom J, Hyyrynen J, Korpela R, Karhunen ML, et al. 2004. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J. Hum. Hypertens. 18:795-802
80. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The Human Microbiome Project. Nature 449:804-10
81. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, et al. 2006. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55:182-90
82. Vinderola G, Matar C, Perdigon G. 2005. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of Toll-like receptors. Clin. Diagn. Lab. Immunol. 12:1075-84
83. Yamano T, Tanida M, Niijima A, Maeda K, Okumura N, et al. 2006. Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci. 79:1963-67